Lexeo Therapeutics (LXEO) Accumulated Depreciation (2022 - 2026)
Lexeo Therapeutics (LXEO) reported Accumulated Depreciation of $887,000 for Q2 2026, up 48.8% from $596,000 a year earlier and up 9.0% from the prior quarter.
Powered by 
Analysis
Lexeo Therapeutics (LXEO) Accumulated Depreciation (2022 - 2026) Analysis & Trends
At the end of FY2025, Lexeo Therapeutics posted Accumulated Depreciation of $741,000, up 56.3% from FY2024.
- Accumulated Depreciation has increased for three consecutive years, with a three-year compound annual growth rate of 77.3% (FY2022 to FY2025).
- By year, Accumulated Depreciation came in at $474,000 in FY2024 (+24.4%), $381,000 in FY2023 (+186.5%) and $133,000 in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Accumulated Depreciation in data going back to Q4 2022.
- Year over year, Accumulated Depreciation has now increased in each of the last eight quarters, with growth averaging 39.5% over the last eight quarters.
- Over the past five years, the year-over-year growth in Accumulated Depreciation ranged from 9.5% (Q3 2025) to 186.5% (Q4 2023).
- Per Business Quant data, the three quarters before Q2 2026 came in at $814,000 (Q1 2026), $741,000 (Q4 2025) and $668,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Lexeo Therapeutics | 265.74 Mn | 265.74 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 887,000.00 |
| Mar 31, 2026 | 814,000.00 |
| Dec 31, 2025 | 741,000.00 |
| Sep 30, 2025 | 668,000.00 |
| Jun 30, 2025 | 596,000.00 |
| Mar 31, 2025 | 534,000.00 |
| Dec 31, 2024 | 474,000.00 |
| Sep 30, 2024 | 610,000.00 |
| Jun 30, 2024 | 527,000.00 |
| Mar 31, 2024 | 450,000.00 |
| Dec 31, 2023 | 381,000.00 |
| Sep 30, 2023 | 316,000.00 |
| Dec 31, 2022 | 133,000.00 |
API Access
Lexeo Therapeutics Accumulated Depreciation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=LXEO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-depreciation", "ticker": "LXEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=LXEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();